Recruiting studies: Fap

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergo
Phase N/A · 2 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT04678011 Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
Phase 1 · 5 location(s) · National Cancer Institute (NCI) · NCT05630794 Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3 · 15 location(s) · SOFIE · NCT07217717 Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815 ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Phase N/A · 40 location(s) · Alnylam Pharmaceuticals · NCT04561518 Comprehensive Program for Hereditary Transthyretin Amyloidosis
Phase N/A · 1 location(s) · Hospital de Alta Complejidad en Red · NCT07213297 AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 · 3 location(s) · Avacta Life Sciences Ltd · NCT07454642 Pain in Pediatric Patients - Internet Interventions for Disorders of Gut-brain Interaction
NA · 1 location(s) · Karolinska Institutet · NCT07319078 Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
NA · 1 location(s) · Jules Bordet Institute · NCT06107608 A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Xinlu Wang · NCT06197139 Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Phase 3 · 29 location(s) · Rapamycin Holdings Inc. · NCT06950385 A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
Phase 1 · 1 location(s) · Ruimin Wang · NCT06211647 Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Phase 2 · 1 location(s) · Oregon Health and Science University · NCT05758493 Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Phase 1/Phase 2 · 1 location(s) · HonorHealth Research Institute · NCT07463599 Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
NA · 1 location(s) · Massachusetts General Hospital · NCT05577819 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG
NA · 1 location(s) · The First Affiliated Hospital of Xiamen University · NCT05873777 A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Phase N/A · 26 location(s) · Akcea Therapeutics · NCT04850105 Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07516288 TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · 41 location(s) · Alnylam Pharmaceuticals · NCT07223203 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Chongqing Medical University · NCT06387381 Using FAPI PET/MRI to Evaluate Prostate Cancer
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06675357 TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Phase 3 · 240 location(s) · Alnylam Pharmaceuticals · NCT07052903 A Phase 3 Study of NTLA-2001 in ATTRv-PN
Phase 3 · 14 location(s) · Intellia Therapeutics · NCT06672237 MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · 132 location(s) · Intellia Therapeutics · NCT06128629 A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability,
Phase 1/Phase 2 · 3 location(s) · YolTech Therapeutics Co., Ltd · NCT06539208 Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) P
Phase 3 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT07613099 The Italian Transthyretin Amyloidosis Web-Network
Phase N/A · 30 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT05444920 Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268 Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
Phase N/A · 1 location(s) · Western Sydney Local Health District · NCT03471403 Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients
Phase 1 · 2 location(s) · Chengdu New Radiomedicine Technology Co. LTD. · NCT06911489

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.